To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Magnus Gisslen - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Contact form


Note! If you want an answer on a question you must specify your email address

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg

Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
Aylin Yilmaz, Dietmar Fuchs, Richard W Price, Serena Spudich, Kaj Blennow et al.
Current HIV/AIDS reports, Review article 2019
Review article

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Magnus Gisslén, Amanda Heslegrave, E. Veleva, A. Yilmaz, L. M. Andersson et al.
Neurology-Neuroimmunology & Neuroinflammation, Journal article 2019
Journal article

Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur et al.
Journal of neurovirology, Journal article 2018
Journal article

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Sarah B Joseph, Laura P Kincer, Natalie M Bowman, Chris Evans, Michael J Vinikoor et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Journal article 2018
Journal article

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Showing 91 - 100 of 166


Raltegravir cerebrospinal fluid concentrations in HIV-1 infection
Aylin Yilmaz, Magnus Gisslén, S Spudich, E Lee, A Jayewardene et al.
PLoS One, Journal article 2009
Journal article

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals
Aylin Yilmaz, Arash Izadkhasthi, R. W. Price, PW Mallon, M De Meulder et al.
AIDS Research and Human Retroviruses, Journal article 2009
Journal article

Treatment of HIV infection: Swedish recommendations 2009.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström et al.
Scandinavian journal of infectious diseases, Review article 2009
Review article

Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, Patrik Medstrand, Christer Owman et al.
AIDS research and human retroviruses, Journal article 2009
Journal article

The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patients
Filip Josephson, Maria CH Andersson, L. Flamholc, Magnus Gisslén, Lars Hagberg et al.
European Journal Clinical Pharmacology, Journal article 2009
Journal article

Sexuellt överförbara sjukdomar
Magnus Gisslén, G Johannisson, Karin Rignér
Läkemedelsboken 2009/2010, Chapter in book 2009
Chapter in book


Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
Aylin Yilmaz, R. W. Price, S. Spudich, Dietmar Fuchs, Lars Hagberg et al.
Journal of Acquired Immune Deficiency Syndromes, Journal article 2008
Journal article

Showing 91 - 100 of 166

Page Manager: Webmaster|Last update: 4/19/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?